MSB 1.02% 99.0¢ mesoblast limited

Gene therapy drug approval granted

  1. 916 Posts.
    lightbulb Created with Sketch. 73
    Gene therapy drug approval granted to GSK
    www.bbc.com/news/science-environment-36400206

    "One of the issues for Big Pharma is how can it make money out of gene therapy. If one treatment cures its customers then is the industry not in danger of putting itself out of business?

    GSK's position and those of other drug companies is that it can't afford not to become involved in gene therapy.
    If the vision to treat people with one-off treatments that last a long time becomes a reality, any part of the industry that chooses to ignore gene therapy will be in an awful lot of trouble.

    So the time is now right for large drug companies companies to become involved in gene therapy again. The question for Big Pharma the how much to charge for a single life-long cure? "

    I like this bit:
    "If the vision to treat people with one-off treatments that last a long time becomes a reality, any part of the industry that chooses to ignore gene therapy will be in an awful lot of trouble."

    Don't really know the difference between stem cell therapy & gene therapy and the costing.
    If we replace "gene therapy" with "stem cell therapy" . Bingooooo.
    They are in the same boat, except gene therapy had been approved recently.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
99.0¢
Change
0.010(1.02%)
Mkt cap ! $1.130B
Open High Low Value Volume
99.5¢ $1.02 98.5¢ $5.507M 5.501M

Buyers (Bids)

No. Vol. Price($)
1 9996 99.0¢
 

Sellers (Offers)

Price($) Vol. No.
99.5¢ 18069 3
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.